Dramatic Response to Teriprilumab and Anlotinib Combination...

JTO Clinical and Research Reports 2020 / 06 Vol. 1; Iss. 2

Dramatic Response to Teriprilumab and Anlotinib Combination Therapy in a patient with EGFR-Mutant Lung Adenocarcinoma Who Experienced Small-Cell Transformation−Mediated Erlotinib Resistance After Failure of Chemotherapy

Zhou, Yuling, Zeng, Liang, Yang, Nong, Zhang, Yongchang
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
1
Journal:
JTO Clinical and Research Reports
DOI:
10.1016/j.jtocrr.2020.100010
Date:
June, 2020
File:
PDF, 1.52 MB
2020
Conversion to is in progress
Conversion to is failed